AnalysisBusiness
3 hours ago
Featured
Investor Clive Meanwell bets on AI in biotech after $10B bidding war
Clive Meanwell, who sold obesity startup Metsera in a $10B bidding war, is now backing AI-driven biotechs. He argues AI can catalyze population-health-focused drug development, moving beyond traditional rare-disease models.
·
3 hours ago